151 related articles for article (PubMed ID: 22981725)
41. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
[TBL] [Abstract][Full Text] [Related]
42. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
43. Clicked tacrine conjugates as acetylcholinesterase and β-amyloid directed compounds.
Ouberai M; Brannstrom K; Vestling M; Olofsson A; Dumy P; Chierici S; Garcia J
Org Biomol Chem; 2011 Feb; 9(4):1140-7. PubMed ID: 21152577
[TBL] [Abstract][Full Text] [Related]
44. Interaction of PiB-derivative metal complexes with beta-amyloid peptides: selective recognition of the aggregated forms.
Martins AF; Dias DM; Morfin JF; Lacerda S; Laurents DV; Tóth É; Geraldes CF
Chemistry; 2015 Mar; 21(14):5413-22. PubMed ID: 25712142
[TBL] [Abstract][Full Text] [Related]
45. Gantenerumab: a novel human anti-Aβ antibody demonstrates sustained cerebral amyloid-β binding and elicits cell-mediated removal of human amyloid-β.
Bohrmann B; Baumann K; Benz J; Gerber F; Huber W; Knoflach F; Messer J; Oroszlan K; Rauchenberger R; Richter WF; Rothe C; Urban M; Bardroff M; Winter M; Nordstedt C; Loetscher H
J Alzheimers Dis; 2012; 28(1):49-69. PubMed ID: 21955818
[TBL] [Abstract][Full Text] [Related]
46. Amyloid peptide Aβ40 inhibits aggregation of Aβ42: evidence from molecular dynamics simulations.
Viet MH; Li MS
J Chem Phys; 2012 Jun; 136(24):245105. PubMed ID: 22755606
[TBL] [Abstract][Full Text] [Related]
47. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
Zhou B; Li CL; Hao YQ; Johnny MC; Liu YN; Li J
Bioorg Med Chem; 2013 Jan; 21(2):395-402. PubMed ID: 23245572
[TBL] [Abstract][Full Text] [Related]
48. Direct observation of Abeta amyloid fibril growth and inhibition.
Ban T; Hoshino M; Takahashi S; Hamada D; Hasegawa K; Naiki H; Goto Y
J Mol Biol; 2004 Nov; 344(3):757-67. PubMed ID: 15533443
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of aggregation of amyloid peptides by beta-sheet breaker peptides and their binding affinity.
Viet MH; Ngo ST; Lam NS; Li MS
J Phys Chem B; 2011 Jun; 115(22):7433-46. PubMed ID: 21563780
[TBL] [Abstract][Full Text] [Related]
50. Surface plasmon resonance for the analysis of beta-amyloid interactions and fibril formation in Alzheimer's disease research.
Aguilar MI; Small DH
Neurotox Res; 2005; 7(1-2):17-27. PubMed ID: 15639795
[TBL] [Abstract][Full Text] [Related]
51. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
Narayanan S; Kamps B; Boelens WC; Reif B
FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
[TBL] [Abstract][Full Text] [Related]
52. Cerebrospinal fluid of Alzheimer patients promotes beta-amyloid fibril formation in vitro.
Ono K; Noguchi M; Matsumoto Y; Yanase D; Iwasa K; Naiki H; Yamada M
Neurobiol Dis; 2005 Nov; 20(2):233-40. PubMed ID: 16242632
[TBL] [Abstract][Full Text] [Related]
53. Aβ peptide fibrillar architectures controlled by conformational constraints of the monomer.
Brännström K; Ohman A; Olofsson A
PLoS One; 2011; 6(9):e25157. PubMed ID: 21980388
[TBL] [Abstract][Full Text] [Related]
54. Resveratrol and Amyloid-Beta: Mechanistic Insights.
Jia Y; Wang N; Liu X
Nutrients; 2017 Oct; 9(10):. PubMed ID: 29036903
[TBL] [Abstract][Full Text] [Related]
55. Nuclear magnetic resonance evidence for the dimer formation of beta amyloid peptide 1-42 in 1,1,1,3,3,3-hexafluoro-2-propanol.
Shigemitsu Y; Iwaya N; Goda N; Matsuzaki M; Tenno T; Narita A; Hoshi M; Hiroaki H
Anal Biochem; 2016 Apr; 498():59-67. PubMed ID: 26772162
[TBL] [Abstract][Full Text] [Related]
56. Effects of Congo red on aβ(1-40) fibril formation process and morphology.
Pratim Bose P; Chatterjee U; Xie L; Johansson J; Göthelid E; Arvidsson PI
ACS Chem Neurosci; 2010 Apr; 1(4):315-24. PubMed ID: 22778828
[TBL] [Abstract][Full Text] [Related]
57. In Silico and in Vitro Study of Binding Affinity of Tripeptides to Amyloid β Fibrils: Implications for Alzheimer's Disease.
Viet MH; Siposova K; Bednarikova Z; Antosova A; Nguyen TT; Gazova Z; Li MS
J Phys Chem B; 2015 Apr; 119(16):5145-55. PubMed ID: 25815792
[TBL] [Abstract][Full Text] [Related]
58. Polyphenols Modulate Alzheimer's Amyloid Beta Aggregation in a Structure-Dependent Manner.
Phan HTT; Samarat K; Takamura Y; Azo-Oussou AF; Nakazono Y; Vestergaard MC
Nutrients; 2019 Mar; 11(4):. PubMed ID: 30935135
[TBL] [Abstract][Full Text] [Related]
59. Kinetic modeling and determination of reaction constants of Alzheimer's beta-amyloid fibril extension and dissociation using surface plasmon resonance.
Hasegawa K; Ono K; Yamada M; Naiki H
Biochemistry; 2002 Nov; 41(46):13489-98. PubMed ID: 12427009
[TBL] [Abstract][Full Text] [Related]
60. Role of norepinephrine in Aβ-related neurotoxicity: dual interactions with Tyr10 and SNK(26-28) of Aβ.
Liu M; Wan L; Bin Y; Xiang J
Acta Biochim Biophys Sin (Shanghai); 2017 Feb; 49(2):170-178. PubMed ID: 28069584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
